Alphatec Holdings, Inc. (NASDAQ:ATEC) is among the 14 best booming stocks to buy right now. On January 12, the company announced preliminary 2025 financial results and provided its 2026 outlook.
Preliminary total revenue increased 25% for the full year and is expected to be between $763.4 million and $764.4 million, driven primarily by a 26% surge in surgical revenue. The company also reaffirmed its full-year guidance for adjusted EBITDA of $91 million. It ended the year with a cash balance of $161 million.
For fiscal 2026, Alphatec Holdings, Inc. has projected a revenue of $890 million, of which 90% is expected to be surgical-related. Adjusted EBITDA is anticipated to be around $130 million, while free cash flow for the year is forecast at approximately $20 million.
On the same day, the company announced a strategic agreement with Theradaptive, Inc., under which it would acquire exclusive distribution rights in the United States for Theradaptive’s rhBMP-2 solution, OsteoAdapt. The move is set to further strengthen Alphatec Holdings, Inc. position in the procedural ecosystem.
Following these developments, Needham and HC Wainwright & Co. reiterated their Buy ratings for the stocks, with price targets of $22 and $24, respectively.
Wall Street has a bullish outlook on the company with a consensus Strong Buy rating. The stock has a one-year average share price target of $24.55, representing an upside of nearly 40%, as of the close on January 12.
Alphatec Holdings, Inc. is a medical device company focused on the development of technologies for improved surgical treatment of spinal disorders.
READ NEXT: 14 Best S&P 500 Stocks to Buy Now and 11 Most Oversold S&P 500 Stocks Heading into 2026
